CINIE CINIE
中文 | English | Français | Русский
Home CINIE World Nuclear Fusion Nuclear Application

Search Results

Keyword:medical use licensing

NRC to Hold Online Public Meeting on Proposed Medical Use Licensing Rule

NRC to Hold Online Public Meeting on Proposed Medical Use Licensing Rule

The U.S. Nuclear Regulatory Commission recently announced it will hold an online public meeting from 1:00 p.m. to 2:30 p.m. Eastern Time on August 20 to introduce the proposed rule aimed at reducing barriers to medical use licensing. The proposed rule was published in the Federal Register on July 27. During the meeting, NRC staff will outline the key provisions of the rule and related implementation activities, and answer questions from the public. The meeting is open to the public and will focus on regulatory processes related to medical use licensing, with the goal of explaining and discussing the proposed rule and subsequent implementation arrangements...

2026-08-16

Reading Ranking

  • 1 Indiana Launches "Nuclear Ready Communities Program" Applications: Promoting Clean Nuclear Energy Investment to Empower High-Tech Industry Development
  • 2 South China Regulatory Station Strengthens Fusion Device Regulation to Empower New Technology Development
  • 3 Joint Institute for High Temperatures of the Russian Academy of Sciences Discovers a New Phase Transition in Cesium Plasma: Abrupt Conductivity Jump and a Rare Double Critical Point
  • 4 German Research Team Completes First Phase Analysis of Chernobyl "Hot Particles": Nuclear Fuel Crystal Structure Still Exhibits Unexpectedly High Chemical Stability After 40 Years
  • 5 World Nuclear Industry Status Report: The Global "Nuclear Renaissance" Is in Fact "Single-Engine Driven by China," with Regions Outside China in "Substantial Stagnation"
  • 6 The Chinese Academy of Sciences launches the "Scientific Frontier Extreme Breakthrough Program": the first batch deploys major tasks such as "new element synthesis," relying on large scientific facility clusters to push the limits of nuclear physics and materials science
  • 7 Innovating the Safety Review Pathway to Strengthen the Safety Foundation of High-Temperature Gas-Cooled Reactors — National Nuclear Safety Administration Approves Safety Design Criteria for High-Temperature Gas-Cooled Reactors
  • 8 "Major National Heavy Equipment · Industrial Answer Sheet" In-Depth Analysis of Independent Supporting of Core Parts of China's Hualong One
  • 9 GE HealthCare Plans $945 Million All-Cash Acquisition of Sofie Biosciences: Full-Scale Positioning in the "Final Mile" Delivery of Positron Radiopharmaceuticals and CDMO Capacity
  • 10 Cumulative safe power generation of China's Sanmen Nuclear Power Phase I exceeds 150 billion kWh
  • 11 CGN and the People's Government of Sichuan Province Sign a Strategic Cooperation Agreement
  • 12 Construction of the "Helong-2" project begins, advancing toward hydrogen-boron fusion power generation
  • 13 Bulgarian experts state that restarting the Belene nuclear power plant is technically feasible
  • 14 Standard Technical Specifications for Passive Nuclear Power Plants, Chiefly Compiled Under the Leadership of Shanghai Nuclear Engineering Research and Design Institute, Officially Released
  • 15 At the American Society for Radiation Oncology annual meeting, phase 3 clinical results were announced: SBRT radiotherapy for localized prostate cancer achieves long-term control rates comparable to radical prostatectomy and greatly reduces the risk of incontinence.
CINIE

Organizing Committee of the Shenzhen Nuclear Expo

Telephone: +86 10-67808008

+86 10-68808008

Email: info@cinie.net

CINIE

Event Overview News Center Support Services Highlights Archive Contact Us

World Nuclear

China Nuclear Power News World Nuclear Power News Expert Views Nuclear Power Technology

Fusion

China Fusion World Fusion Big Science Facilities ITER Program Business & Capital

Nuclear Application

Medical Scientific Research Environmental Protection Industry Food Agriculture Security
About us | All rights reserved
CINIE All rights reserved 2026 ICP License:京ICP备12027382号-9